Cargando…

BDNF-Val66Met-Polymorphism Impact on Cortical Plasticity in Schizophrenia Patients: A Proof-of-Concept Study

BACKGROUND: Brain-derived neurotrophic factor (BDNF) has been shown to be a moderator of neuroplasticity. A frequent BDNF-polymorphism (Val66Met) is associated with impairments of cortical plasticity. In patients with schizophrenia, reduced neuroplastic responses following non-invasive brain stimula...

Descripción completa

Detalles Bibliográficos
Autores principales: Strube, Wolfgang, Nitsche, Michael A., Wobrock, Thomas, Bunse, Tilmann, Rein, Bettina, Herrmann, Maximiliane, Schmitt, Andrea, Nieratschker, Vanessa, Witt, Stephanie H., Rietschel, Marcella, Falkai, Peter, Hasan, Alkomiet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360229/
https://www.ncbi.nlm.nih.gov/pubmed/25612896
http://dx.doi.org/10.1093/ijnp/pyu040
_version_ 1782361518660124672
author Strube, Wolfgang
Nitsche, Michael A.
Wobrock, Thomas
Bunse, Tilmann
Rein, Bettina
Herrmann, Maximiliane
Schmitt, Andrea
Nieratschker, Vanessa
Witt, Stephanie H.
Rietschel, Marcella
Falkai, Peter
Hasan, Alkomiet
author_facet Strube, Wolfgang
Nitsche, Michael A.
Wobrock, Thomas
Bunse, Tilmann
Rein, Bettina
Herrmann, Maximiliane
Schmitt, Andrea
Nieratschker, Vanessa
Witt, Stephanie H.
Rietschel, Marcella
Falkai, Peter
Hasan, Alkomiet
author_sort Strube, Wolfgang
collection PubMed
description BACKGROUND: Brain-derived neurotrophic factor (BDNF) has been shown to be a moderator of neuroplasticity. A frequent BDNF-polymorphism (Val66Met) is associated with impairments of cortical plasticity. In patients with schizophrenia, reduced neuroplastic responses following non-invasive brain stimulation have been reported consistently. Various studies have indicated a relationship between the BDNF-Val66Met-polymorphism and motor-cortical plasticity in healthy individuals, but schizophrenia patients have yet to be investigated. The aim of this proof-of-concept study was, therefore, to test the impact of the BDNF-Val66Met-polymorphism on inhibitory and facilitatory cortical plasticity in schizophrenia patients. METHODS: Cortical plasticity was investigated in 22 schizophrenia patients and 35 healthy controls using anodal and cathodal transcranial direct-current stimulation (tDCS) applied to the left primary motor cortex. Animal and human research indicates that excitability shifts following anodal and cathodal tDCS are related to molecular long-term potentiation and long-term depression. To test motor-cortical excitability before and after tDCS, well-established single- and paired-pulse transcranial magnetic stimulation protocols were applied. RESULTS: Our analysis revealed increased glutamate-mediated intracortical facilitation in met-heterozygotes compared to val-homozygotes at baseline. Following cathodal tDCS, schizophrenia met-heterozygotes had reduced gamma-amino-butyric-acid-mediated short-interval intracortical inhibition, whereas healthy met-heterozygotes displayed the opposite effect. The BDNF-Val66Met-polymorphism did not influence single-pulse motor-evoked potential amplitudes after tDCS. CONCLUSIONS: These preliminary findings support the notion of an association of the BDNF-Val66Met-polymorphism with observable alterations in plasticity following cathodal tDCS in schizophrenia patients. This indicates a complex interaction between inhibitory intracortical interneuron-networks, cortical plasticity, and the BDNF-Val66Met-polymorphism. Further replication and validation need to be dedicated to this question to confirm this relationship.
format Online
Article
Text
id pubmed-4360229
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-43602292015-09-01 BDNF-Val66Met-Polymorphism Impact on Cortical Plasticity in Schizophrenia Patients: A Proof-of-Concept Study Strube, Wolfgang Nitsche, Michael A. Wobrock, Thomas Bunse, Tilmann Rein, Bettina Herrmann, Maximiliane Schmitt, Andrea Nieratschker, Vanessa Witt, Stephanie H. Rietschel, Marcella Falkai, Peter Hasan, Alkomiet Int J Neuropsychopharmacol Research Article BACKGROUND: Brain-derived neurotrophic factor (BDNF) has been shown to be a moderator of neuroplasticity. A frequent BDNF-polymorphism (Val66Met) is associated with impairments of cortical plasticity. In patients with schizophrenia, reduced neuroplastic responses following non-invasive brain stimulation have been reported consistently. Various studies have indicated a relationship between the BDNF-Val66Met-polymorphism and motor-cortical plasticity in healthy individuals, but schizophrenia patients have yet to be investigated. The aim of this proof-of-concept study was, therefore, to test the impact of the BDNF-Val66Met-polymorphism on inhibitory and facilitatory cortical plasticity in schizophrenia patients. METHODS: Cortical plasticity was investigated in 22 schizophrenia patients and 35 healthy controls using anodal and cathodal transcranial direct-current stimulation (tDCS) applied to the left primary motor cortex. Animal and human research indicates that excitability shifts following anodal and cathodal tDCS are related to molecular long-term potentiation and long-term depression. To test motor-cortical excitability before and after tDCS, well-established single- and paired-pulse transcranial magnetic stimulation protocols were applied. RESULTS: Our analysis revealed increased glutamate-mediated intracortical facilitation in met-heterozygotes compared to val-homozygotes at baseline. Following cathodal tDCS, schizophrenia met-heterozygotes had reduced gamma-amino-butyric-acid-mediated short-interval intracortical inhibition, whereas healthy met-heterozygotes displayed the opposite effect. The BDNF-Val66Met-polymorphism did not influence single-pulse motor-evoked potential amplitudes after tDCS. CONCLUSIONS: These preliminary findings support the notion of an association of the BDNF-Val66Met-polymorphism with observable alterations in plasticity following cathodal tDCS in schizophrenia patients. This indicates a complex interaction between inhibitory intracortical interneuron-networks, cortical plasticity, and the BDNF-Val66Met-polymorphism. Further replication and validation need to be dedicated to this question to confirm this relationship. Oxford University Press 2015-01-21 /pmc/articles/PMC4360229/ /pubmed/25612896 http://dx.doi.org/10.1093/ijnp/pyu040 Text en © The Author 2015. Published by Oxford University Press on behalf of CINP. http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Research Article
Strube, Wolfgang
Nitsche, Michael A.
Wobrock, Thomas
Bunse, Tilmann
Rein, Bettina
Herrmann, Maximiliane
Schmitt, Andrea
Nieratschker, Vanessa
Witt, Stephanie H.
Rietschel, Marcella
Falkai, Peter
Hasan, Alkomiet
BDNF-Val66Met-Polymorphism Impact on Cortical Plasticity in Schizophrenia Patients: A Proof-of-Concept Study
title BDNF-Val66Met-Polymorphism Impact on Cortical Plasticity in Schizophrenia Patients: A Proof-of-Concept Study
title_full BDNF-Val66Met-Polymorphism Impact on Cortical Plasticity in Schizophrenia Patients: A Proof-of-Concept Study
title_fullStr BDNF-Val66Met-Polymorphism Impact on Cortical Plasticity in Schizophrenia Patients: A Proof-of-Concept Study
title_full_unstemmed BDNF-Val66Met-Polymorphism Impact on Cortical Plasticity in Schizophrenia Patients: A Proof-of-Concept Study
title_short BDNF-Val66Met-Polymorphism Impact on Cortical Plasticity in Schizophrenia Patients: A Proof-of-Concept Study
title_sort bdnf-val66met-polymorphism impact on cortical plasticity in schizophrenia patients: a proof-of-concept study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360229/
https://www.ncbi.nlm.nih.gov/pubmed/25612896
http://dx.doi.org/10.1093/ijnp/pyu040
work_keys_str_mv AT strubewolfgang bdnfval66metpolymorphismimpactoncorticalplasticityinschizophreniapatientsaproofofconceptstudy
AT nitschemichaela bdnfval66metpolymorphismimpactoncorticalplasticityinschizophreniapatientsaproofofconceptstudy
AT wobrockthomas bdnfval66metpolymorphismimpactoncorticalplasticityinschizophreniapatientsaproofofconceptstudy
AT bunsetilmann bdnfval66metpolymorphismimpactoncorticalplasticityinschizophreniapatientsaproofofconceptstudy
AT reinbettina bdnfval66metpolymorphismimpactoncorticalplasticityinschizophreniapatientsaproofofconceptstudy
AT herrmannmaximiliane bdnfval66metpolymorphismimpactoncorticalplasticityinschizophreniapatientsaproofofconceptstudy
AT schmittandrea bdnfval66metpolymorphismimpactoncorticalplasticityinschizophreniapatientsaproofofconceptstudy
AT nieratschkervanessa bdnfval66metpolymorphismimpactoncorticalplasticityinschizophreniapatientsaproofofconceptstudy
AT wittstephanieh bdnfval66metpolymorphismimpactoncorticalplasticityinschizophreniapatientsaproofofconceptstudy
AT rietschelmarcella bdnfval66metpolymorphismimpactoncorticalplasticityinschizophreniapatientsaproofofconceptstudy
AT falkaipeter bdnfval66metpolymorphismimpactoncorticalplasticityinschizophreniapatientsaproofofconceptstudy
AT hasanalkomiet bdnfval66metpolymorphismimpactoncorticalplasticityinschizophreniapatientsaproofofconceptstudy